strong start freseniu medic bode
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research may
estim feb
price data may
rate updat may
currenc amount express
methodolog valu compani
freseniu medic report first quarter fell
within expect encourag firm
begin year track well full-year outlook
follow tumultu updat model
intend chang fair valu estim eur per
share per adr narrow-moat franchis
share begin convincingli converg fair
valu highlight peer altern
invest opportun space trade much
steeper discount valuat
lot dislik freseniu result same-
facil treatment growth unit state market
far standout figur opinion
like one best quarterli result last year
mark acceler figur
cours help dialysi servic revenu
firm north american segment expand constant
currenc come well ahead model result
give us ad confid await first-quart
result earli next week also highlight
unexpect diverg report treatment
growth two compani late last year
profit across enterpris met expect
stabil north american segment help
strong global perform
previous announc freseniu final close
acquisit nxstage medic quarter busi
expect begin contribut oper profit
look increas penetr
system one home hemodialysi devic freseniu
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
davita inc largest provid dialysi servic boast
market share level eclips measur patient clinic
firm oper facil world-wide locat
unit state treat patient global year
manag began build fledgl intern busi
anticip busi need continu expand
garner scale need earn attract return govern payer
domin dialysi reimburs -- receiv approxim
 sale medicar medicaid reimburs rate
remain come commerci insur
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
ownership key indic success
pleas see recent report attract dialysi
econom support provid moat deeper dive
home dialysi market opportun
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
incom equiti invest
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
equival
net properti plant equip
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
